Table 1

Demographic/clinical data of the spondyloarthritis patients

Cohort 1Cohort 2Cohort 3Cohort 4
No. patients20101115
TreatmentInfliximabEtanerceptAdalimumabNo TNF blocker
Age (years)44 (±12)45 (±18)47 (±15)48 (±12)
Gender80% male70% male64% male80% male
Disease duration (years)12 (±9)10 (±8)9 (±7)12 (±10)
BASDAI6.3 (±2.0)5.8 (±2.3)6.3 (±1.8)2.1 (±1.0)
CRP mg/l13.2 (±10.8)9.2 (±6.7)10.2 (±8.7)2.8 (±1.9)
  • BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; CRP, C-reactive protein. Data are expressed as mean (SD).